DESTINY-Gastric01: Trastuzumab Deruxtecan in Previously Treated, HER2+ Advanced Gastric or GEJ Adenocarcinoma

Module from Clinical Care Options (CCO): Christine Chio, PharmD, BCOP; Lipika Goyal, MD; and Caroline Kuhlman, NP, discuss current treatment of cholangiocarcinoma, including the use of biomarkers

Christine Chio, PharmD, BCOP Lipika Goyal, MD Caroline Kuhlman, NP Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: May 13, 2022 Expired: May 12, 2023

Review this slideset on the current treatment of cholangiocarcinoma with expert perspectives from Christine Chio, PharmD, BCOP; Lipika Goyal, MD; and Caroline Kuhlman, NP.

Christine Chio, PharmD, BCOP Lipika Goyal, MD Caroline Kuhlman, NP Released: May 13, 2022

On-demand webcast on HER2, HER3, and TROP2 antibody-drug conjugates in breast, gastrointestinal, and lung cancers, from Clinical Care Options (CCO)

Aditya Bardia, MD, MPH Yelena Y. Janjigian, MD Sandip P. Patel, MD Physicians: maximum of 2.0 AMA PRA Category 1 Credits™ Released: May 11, 2022 Expired: May 10, 2023

Video from Clinical Care Options (CCO): Expert insights on biomarker-driven treatment for gastrointestinal (GI) cancers

Pashtoon M. Kasi, MD, MS Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: April 28, 2022 Expired: April 27, 2023